Recent advances in quantitative high throughput and high content data analysis
Author:
Funder
Novartis
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460441.2016.1154036
Reference86 articles.
1. Biomarkers in pharmacology and drug discovery
2. Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells
3. Drugs for bad bugs: confronting the challenges of antibacterial discovery
4. How were new medicines discovered?
5. The discovery of first-in-class drugs: origins and evolution
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. KiRNet: Kinase-centered network propagation of pharmacological screen results;Cell Reports Methods;2021-06
2. The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery;RSC Medicinal Chemistry;2021
3. High-Throughput Screening: today’s biochemical and cell-based approaches;Drug Discovery Today;2020-10
4. KiRNet: Integrated, Kinase-Centered Network Modeling Predicts Mechanisms Behind Phenotypic Associations;SSRN Electronic Journal;2020
5. Requirements of skin tissue models for high-throughput screening;Skin Tissue Models for Regenerative Medicine;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3